Maintenance of remission over 1 year in patients with active Crohn's disease treated with adalimumab: Results of a blinded, placebo-controlled study

被引：10
|
作者：
Sandborn, WJ
Hanauer, SB
Lukas, M
Wolf, DC
Isaacs, KL
MacIntosh, DG
Panaccione, R
Rutgeerts, P
Pollack, PF
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Chicago, Ctr Adv Med, Chicago, IL 60637 USA
[3] Charles Univ, CR-11636 Prague, Czech Republic
[4] Atlanta Gastroenterol Assoc, Atlanta, GA USA
[5] Univ N Carolina, Sch Med, Ctr IBD Res, Chapel Hill, NC 27515 USA
[6] Dalhousie Univ, IBD Clin, Halifax, NS B3H 3J5, Canada
[7] Univ Calgary, Calgary, AB T2N 1N4, Canada
[8] UZ Gasthuisberg, Louvain, Belgium
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00843
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
843
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [1] FLUOXETINE FOR MAINTENANCE OF REMISSION AND TO IMPROVE QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE: A PILOT RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Mikocka-Walus, A.
    Hughes, P.
    Bampton, P.
    Gordon, A.
    Campaniello, M.
    Mavrangelos, C.
    Stewart, B.
    Esterman, A.
    Andrews, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 158 - 158
  • [2] Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease: a Pilot Randomized Placebo-Controlled Trial
    Mikocka-Walus, Antonina
    Hughes, Patrick A.
    Bampton, Peter
    Gordon, Andrea
    Campaniello, Melissa A.
    Mavrangelos, Chris
    Stewart, Benjamin J.
    Esterman, Adrian
    Andrews, Jane M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 509 - 514
  • [3] Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
    Schreiber, S.
    Reinisch, W.
    Colombel, J. F.
    Sandborn, W. J.
    Hommes, D. W.
    Robinson, A. M.
    Huang, B.
    Lomax, K. G.
    Pollack, P. F.
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (03): : 213 - 221
  • [4] A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease
    Sutherland, LR
    Martin, F
    Bailey, RJ
    Fedorak, RN
    Poleski, M
    Dallaire, C
    Rossman, R
    Saibil, F
    Lariviere, L
    Meyer, D
    Baker, SJ
    Alvi, AW
    Bass, S
    Blustein, PK
    Bridges, RJ
    Lay, TE
    vanRosendaal, GMA
    Watson, MH
    Clermont, R
    Cockeram, AW
    Mabey, M
    DaCosta, L
    Beck, IT
    Depew, W
    Groll, A
    Paterson, W
    Simon, J
    Vanner, S
    DAmore, D
    Sherbaniuk, R
    Cherry, R
    Lalor, E
    Thomson, ABR
    Yacyshyn, B
    Bain, V
    Fisher, D
    Kirdeikis, P
    Halle, P
    Irvine, EJ
    Collins, SM
    Croitoru, K
    Crowe, SE
    Goodacre, RL
    Hunt, RH
    Sabena, BJ
    Donnelly, M
    Khan, MAR
    Langevin, S
    Menard, DB
    Haddad, H
    GASTROENTEROLOGY, 1997, 112 (04) : 1069 - 1077
  • [5] Remission and clinical response induced and maintained in patients with active Crohn's disease treated for 1-year open-label with adalimumab
    Sandborn, WJ
    Hanauer, SB
    Lukas, M
    Wolf, DC
    Isaacs, KL
    MacIntosh, DG
    Panaccione, R
    Rutgeerts, P
    Pollack, PF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S316 - S317
  • [6] Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
    Watanabe, Mamoru
    Hibi, Toshifumi
    Lomax, Kathleen G.
    Paulson, Susan K.
    Chao, Jingdong
    Alam, M. Shamsul
    Camez, Anne
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 160 - 173
  • [7] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
  • [8] Randomised, Double-Blinded, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohns Disease
    Willert, Robert P.
    Peddi, Kiran K.
    Ombiga, John
    Bampton, Peter A.
    Lawrance, Ian C.
    GASTROENTEROLOGY, 2010, 138 (05) : S517 - S518
  • [9] Randomised, double-blinded, placebo-controlled study of VSL#3 versus placebo in the maintenance of remission in Crohns disease
    Peddi, P. K. K.
    Ombiga, J.
    Willert, R.
    Bampton, P.
    Lawrance, I. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A317 - A317
  • [10] Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial
    Hanauer, S
    Sandborn, WJ
    Persson, A
    Persson, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (04) : 363 - 371
12345